Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study

Volume: 36, Issue: 12, Pages: 2729 - 2737
Published: Sep 17, 2021
Abstract
The tumour-stroma ratio (TSR) and tumour budding (TB) are two high-risk factors with potential to be implemented in the next TNM classification. The aim of the current study was to evaluate the practical application of the two biomarkers based on reproducibility, independency and prognostic value. Patients diagnosed with stage II or III colon cancer who underwent surgery between 2005 and 2016 were included. Both TSR and TB were scored on...
Paper Details
Title
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
Published Date
Sep 17, 2021
Volume
36
Issue
12
Pages
2729 - 2737
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.